Forefront Analytics, LLC
Position in BCYC — Bicycle Therapeutics PLC
CIK 1696802
WEST CONSHOHOCKEN, PA
Position in BCYC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$92,525
+$25,737 QoQ
Shares Held
21,822
+51.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#58
of 103 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Forefront Analytics, LLC holds $1,763,485 across 9 Biotechnology names. BCYC ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,091 | $577,115 | |
| 2 | LEGN |
Legend Biotech Corp
|
10,568 | $305,203 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
415 | $258,769 | |
| 4 | ZURA |
Zura Bio Ltd
|
26,968 | $159,111 | |
| 5 | GERN |
Geron Corp
|
88,779 | $113,637 | |
| 6 | CTMX |
CytomX Therapeutics, Inc.
|
25,033 | $93,873 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
This page
|
21,822 | $92,525 | |
| 8 | NKTX |
Nkarta, Inc.
|
28,955 | $81,942 |
All Filings in BCYC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,525 | 21,822 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $66,788 | 14,394 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $94,666 | 13,371 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||